Celeste Richardson
11Patents
5h-index
52Co-inventors
61Inventor score
Filing activity: Jul 21, 2015 → Feb 1, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9777061B2 | Treatment of cancer using a CD33 chimeric antigen receptor | Chemistry; Metallurgy | 74 | Active |
| US10174095B2 | Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor | Chemistry; Metallurgy | 27 | Active |
| US11084880B2 | Anti-BCMA chimeric antigen receptor | Chemistry; Metallurgy | 8 | Active |
| US11241485B2 | PDE5 compositions and methods for immunotherapy | Emerging Cross-Sectional Technologies | 7 | Active |
| US11666642B2 | PDE5 compositions and methods for immunotherapy | Emerging Cross-Sectional Technologies | 7 | Active |
| US10568947B2 | Treatment of cancer using a CLL-1 chimeric antigen receptor | Chemistry; Metallurgy | 1 | Active |
| US11058725B2 | CA2 compositions and methods for tunable regulation | Emerging Cross-Sectional Technologies | 1 | Active |
| US10851166B2 | Treatment of cancer using a CD33 chimeric antigen receptor | Chemistry; Metallurgy | 1 | Active |
| US12214037B2 | Treatment of cancer using humanized anti-BCMA chimeric antigen receptor | Chemistry; Metallurgy | 0 | Active |
| US12037583B2 | Compositions and methods for immunooncology | Emerging Cross-Sectional Technologies | 0 | Active |
| US12338287B2 | Treatment of cancer using a CD33 chimeric antigen receptor | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.